Published date: 26 October 2022
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Research and experimental development services - 73100000
Location of contract
SP4 0JQ
Value of contract
£0
Procurement reference
tender_333460/1117788
Published date
26 October 2022
Closing date
25 November 2022
Closing time
5pm
Contract start date
4 April 2023
Contract end date
24 February 2032
Contract type
Service contract
Procedure type
Competitive procedure with negotiation (above threshold)
Anyone may ask to participate, but only those who are pre-selected will be invited to submit initial tenders and to negotiate.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
Development and manufacture of HI-6 DMS powder for solution product. The Authority requires a supplier to provide services for the development, scale-up, clinical and potential future commercial supply. The supplier will be providing product into UK, Canadian and European Union regulatory areas as a minimum. The supplier will provide all supporting manufacturing studies necessary for all stages of product development. The product should be considered light sensitive for the purposes of long-term storage but specific measures should not be necessary for production processes. The Authority will provide the Active Pharmaceutical to the supplier for all activities.
Share this notice
Closing: 25 November 2022, 5pm
All content is available under the
